Wednesday, June 10, 2026

Patent intelligence · US

US 7931640

Method for muscle delivery of drugs, nucleic acids and other compounds

granted A61KA61K2039/53A61K2039/54A61K2039/545
Status granted
Pipeline programs 6
Years to expiry 5
Applicant portfolio 75
Patent details — US 7931640
Jurisdiction
US
Status
granted
Grant date
Apr 26, 2011
Expiration
Apr 21, 2031
Applicant
Inovio AS
Claims
14
CPC classes
A61K, A61K2039/53, A61K2039/54, A61K2039/545
View on Google Patents ↗

Quick answer

US 7931640 (Method for muscle delivery of drugs, nucleic acids and other compounds) is held by Inovio AS. Status: granted. Granted Apr 26, 2011. Expires Apr 21, 2031 (5 years remaining) — relevant for patent-cliff and LOE planning.

Key facts

Applicant
Inovio AS
Grant date
Expiration
Claims
14
CPC classes
A61K, A61K2039/53, A61K2039/54, A61K2039/545, A61K2039/57, A61K39/00

More from Inovio AS

Related pharmaceutical patents in our USPTO index.

  1. US 12285473

    Cancer vaccines targeting MUC16 and uses thereof

    Inovio Pharmaceuticals, Inc. · Expires Apr 24, 2045

    granted
  2. US 12280108

    Vaccines having an antigen and interleukin-21 as an adjuvant

    Inovio Pharmaceuticals, Inc. · Expires Apr 17, 2045

    granted
  3. US 12251561

    Minimally invasive dermal electroporation device

    Inovio Pharmaceuticals, Inc. · Expires Mar 13, 2045

    granted
  4. US 12240872

    Filovirus consensus antigens, nucleic acid constructs and vaccines made therefrom, and methods of using same

    Inovio Pharmaceuticals, Inc. · Expires Feb 27, 2045

    granted
  5. US 12161706

    Cancer vaccines targeting BORIS and uses thereof

    Inovio Pharmaceuticals, Inc. · Expires Dec 5, 2044

    granted
  6. US 12109258

    Synthetic malaria immunogens, combinations thereof, and their use to prevent and treat malaria infections

    Inovio Pharmaceuticals, Inc. · Expires Oct 3, 2044

    granted
  7. US 12064473

    Cancer vaccines targeting Survivin and uses thereof

    Inovio Pharmaceuticals, Inc. · Expires Aug 15, 2044

    granted
  8. US 12053619

    Intradermal jet injection electroporation

    Inovio Pharmaceuticals, Inc. · Expires Aug 1, 2044

    granted

Frequently asked questions

What is US patent 7931640?

US 7931640 (Method for muscle delivery of drugs, nucleic acids and other compounds) is held by Inovio AS. Status: granted. Granted Apr 26, 2011. Expires Apr 21, 2031 (5 years remaining) — relevant for patent-cliff and LOE planning.

Who owns US 7931640?

Inovio AS is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 75 pharmaceutical patents for this assignee.

When does US 7931640 expire?

Our index shows an expiration date of Apr 21, 2031 (5 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.